Reuters logo
BRIEF-Shanghai Shyndec Pharmaceutical gets approval for new drug clinical trial
May 10, 2017 / 9:19 AM / 6 months ago

BRIEF-Shanghai Shyndec Pharmaceutical gets approval for new drug clinical trial

May 10(Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd :

* Says the co received approval from China Food and Drug Administration to start new drug clinical trial for a kind of modified release capsule

* The modified release capsule is antidepressant used for treatment of decreased attention, fatigue and sluggish

* The co will be able to sell modified release capsule after getting approval from China Food and Drug Administration

Source text in Chinese: goo.gl/dsKT5T

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below